The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion

Spine

Volumn 30, Issue 10, 2005, Pages 1134-1138

  Minamide, Akihito ^a   Yoshida, Munehito ^a   Kawakami, Mamoru ^a   Yamasaki, Satoru ^a   Kojima, Hirotsugu ^a   Hashizume, Hiroshi ^a   Boden, Scott D ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow; Bone morphogenetic protein; Hydroxyapatite; Mesenchymal stem cell; Spinal fusion; Type I collagen

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; DEXAMETHASONE; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE GRAFT; BONE MARROW CELL; BONE MATRIX; CELL CULTURE; CELL DIFFERENTIATION; COLLAGEN TYPE 1 GEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; GEL; HISTOLOGY; ILIAC CREST; IMPLANTATION; LUMBAR SPINE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PALPATION; POSTEROLATERAL LUMBER SPINE FUSION; PRIORITY JOURNAL; RABBIT; SPINE FUSION; SPINE RADIOGRAPHY;

ANIMALS; BONE MARROW TRANSPLANTATION; BONE SUBSTITUTES; CELLS, CULTURED; COLLAGEN TYPE I; DURAPATITE; GELS; IMPLANTS, EXPERIMENTAL; LUMBAR VERTEBRAE; MODELS, ANIMAL; OSSEOINTEGRATION; OSTEOGENESIS; RABBITS; SPINAL FUSION;

EID: 18844440475     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.brs.0000162394.75425.04     Document Type: Conference Paper

References (23)

1. Steinman JC, Herkowitz HN. Pseudarthrosis of the spine. Clin Orthop 1992; 284:80-90.
2. Lou J, Xu F, Merkel K, et al. Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999;17:43-50.
3. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-34.
4. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-73.
5. Damien CJ, Grob D, Boden SD, et al. Purified bovine BMP extract and collagen for spine arthrodesis: Preclinical safety and efficacy. Spine 2002;27: S50-8.
6. Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001;26:933-9.
7. Curylo LJ, Johnstone B, Petersilge CA, et al. Augmentation of spinal arthrodesis with autologous bone marrow in a rabbit posterolateral spine fusion model. Spine 1999;24:434-9.
8. Kai T, Shao-qing G, Geng-ting D. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine 2003;28: 1653-8.
9. Lindholm TS, Nilsson OS, Lindholm TC. Extraskeletal and intraskeletal new bone formation induced by demineralized bone matrix combined with bone marrow cells. Clin Orthop 1982;171:251-5.
10. Lindholm TS, Urist MR. A quantitative analysis of new bone formation by induction in composite grafts of bone marrow and bone matrix. Clin Orthop 1980;150:288-300.
11. Ohgushi H, Goldberg VM, Caplan AI. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 1989;7:568-78.
12. Ohgushi H, Dohi Y, Tamai S, et al. Osteogenic differentiation of marrow stromal cells in porous hydroxyapatite ceramics. J Biomed Mater Res 1993; 27:1401-7.
13. Ohgushi H, Dohi Y, Katsuda T, et al. In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 1996;32:333-40.
14. Okumura M, Ohgushi H, Dohi Y, et al. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 1997;37: 122-9.
15. Paley D, Young MDC, Wiley AM, et al. Percutaneous bone marrow grafting of fractures and bony defects: An experimental study in rabbits. Clin Orthop 1986;208:300-12.
16. Teemed JJ, Cannily JF, Strates BS, et al. Treatment of nonunion by percutaneous infection of bone marrow and demineralized bone matrix: An experimental study in dog. Clin Orthop 1991;268:294-302.
17. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: Radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
18. Yoshikawa T, Ohgushi H, Tamai S. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 1996;32:481-92.
19. Boden SD, Martin GJ, Morone M, et al. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 1999;24:320-7.
20. Muschler G, Nitto H, Matsukura Y, et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop 2003;407: 102-18.
21. Takagi K, Urist MR. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop 1982;171:224-31.
22. Werntz JR, Lane JM, Brustein AH, et al. Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res 1996;14:85-93.
23. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res 1999;48:913-27.